Marquette General Cancer Center

 

Brain

 

 

Study Name - TCC Study

 

Study Description -

Cancer Care:  A Partnership with High Risk and/or Diagnosed Cancer Patients for Life

 

IRB Open Date - 04-08-2009

 

Consent-Form

 

Data Privacy Statement for Research Studies

 

 

 

Study Name - KARE 004

 

Study Description -

A Phase II study of Gliadel, Concomitant Temozolomide and Radiation, followed by dose dense therapy with Temozolomide plus Bevacizumab for newly diagnosed malignant high grade Glioma.

 

IRB Open Date - 09-09-2009

 

Consent-Form

 

Data Privacy Statement for Research Studies

 

 

 

Study Name - VEGF

 

Study Description -
This study is looking at the level of vascular endothelial growth factor (VEGF) circulating in the blood stream of patients diagnosed with either a meningioma or a Glioma.

 

IRB Open Date - 09-09-2009

 

Consent-Form

 

Data Privacy Statement for Research Studies

 

<< Back